High concentrations of bioactive glass material (BioGran®) vs. autogenous bone for sinus floor elevation
Identifieur interne : 008489 ( Main/Exploration ); précédent : 008488; suivant : 008490High concentrations of bioactive glass material (BioGran®) vs. autogenous bone for sinus floor elevation
Auteurs : Ette S. Tadjoedin [Pays-Bas] ; Gert L. De Lange [Pays-Bas] ; D. M. Lyaruu [Pays-Bas] ; Luit Kuiper [Pays-Bas] ; Elisabeth H. Burger [Pays-Bas]Source :
- Clinical Oral Implants Research [ 0905-7161 ] ; 2002-08.
English descriptors
- KwdEn :
- 4months, Atrophic maxilla, Augmentation, Autogenous, Autogenous bone, Autogenous bone particles, Bioactive, Bioactive glass, Bioactive glass material, Biopsy, Bone, Bone biopsies, Bone formation, Bone marrow, Bone reconstruction, Bone tissue, Bone volume, Clin, Control side, Dental implants, Elevation, Experimental side, Experimental sides, Goldner staining, Graft, Grafted, High concentration, High concentrations, Histological, Histomorphometrical, Histomorphometry, Hueso, Hueso autogeno, Impl, Implant, Implant placement, Implants research, International journal, Knochen, Lamellar, Lamellar type, Maxilla, Maxillary, Maxillary sinus, Maxillofacial, Maxillofacial implants, Maxillofacial surgery, Meses, Mois, Monaten, Nach, Narrow size range, Oral impl, Osteoid, Osteoid layers, Osteoid surface, Particle, Particules, Preliminary report, Present study, Quatre mois, Resorption, Severe maxillary atrophy, Sinus, Table2, Tadjoedin, Tetracycline, Total bone volume, Trabecular, Trabecular bone, Unstained sections, Xture installation.
- Teeft :
- 4months, Atrophic maxilla, Augmentation, Autogenous, Autogenous bone, Autogenous bone particles, Bioactive, Bioactive glass, Bioactive glass material, Biopsy, Bone, Bone biopsies, Bone formation, Bone marrow, Bone reconstruction, Bone tissue, Bone volume, Clin, Control side, Dental implants, Elevation, Experimental side, Experimental sides, Goldner staining, Graft, Grafted, High concentration, High concentrations, Histological, Histomorphometrical, Histomorphometry, Hueso, Hueso autogeno, Impl, Implant, Implant placement, Implants research, International journal, Knochen, Lamellar, Lamellar type, Maxilla, Maxillary, Maxillary sinus, Maxillofacial, Maxillofacial implants, Maxillofacial surgery, Meses, Mois, Monaten, Nach, Narrow size range, Oral impl, Osteoid, Osteoid layers, Osteoid surface, Particle, Particules, Preliminary report, Present study, Quatre mois, Resorption, Severe maxillary atrophy, Sinus, Table2, Tadjoedin, Tetracycline, Total bone volume, Trabecular, Trabecular bone, Unstained sections, Xture installation.
Abstract
Abstract: In this study, high concentrations of bioactive glass (BG) particles were compared with autogenous bone in their capacity to augment maxillary bone when grafted in the human sinus floor using a split mouth design. Three female patients with severe maxillary atrophy underwent bilateral sinus floor elevation and bone grafting using 80–100% BG particles (300–355 μm in size) mixed with 20% to 0% iliac crest bone particles at one (experimental) side, and 100% iliac crest derived bone particles at the other (control) side. A total of 22 bone biopsies was taken at the time of fixture installation; that is, at 4, 6 and 15 months after grafting, and processed for histology and histomorphometry. At the control (autogenous bone) sides, trabecular bone amounted to 39% of the biopsy volume in the graft (site) at 4 months, almost 41% at 6 months, and 42% at 15 months. This bone contained viable osteocytes and was mostly of mature, lamellar type. At the experimental (BG particles) sides, the graft consisted of 27% of mostly woven (and some lamellar) bone at 4 months, 36% (woven and lamellar) bone at 6 months, and 39% (mainly lamellar) bone at 15 months. The grafted BG particles started to excavate at 4 months and their centers gradually filled with bone tissue. As a consequence, the volume of BG particles in the biopsy decreased from 29% at 4 months to 15% at 6 months and 8% at 15 months. The BG particles appeared to resorb within 1–2 years by dissolution rather than by osteoclastic activity. Parameters for bone turnover (% osteoid surface, % resorption surface) indicated that bone remodeling was very active at both experimental and control sides, during more than 6 months. These results suggest that mixtures of mainly (80–90%) BG particles and some (10–20%) autogenous bone are effective for bone regeneration in the augmented sinus offer 6 months healing time, while about 12 months healing time is needed for 100% BG particles.
Url:
DOI: 10.1034/j.1600-0501.2002.130412.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 005209
- to stream Istex, to step Curation: 005209
- to stream Istex, to step Checkpoint: 003882
- to stream Main, to step Merge: 008766
- to stream Main, to step Curation: 008489
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">High concentrations of bioactive glass material (BioGran®) vs. autogenous bone for sinus floor elevation</title>
<author><name sortKey="Tadjoedin, Ette S" sort="Tadjoedin, Ette S" uniqKey="Tadjoedin E" first="Ette S." last="Tadjoedin">Ette S. Tadjoedin</name>
</author>
<author><name sortKey="De Lange, Gert L" sort="De Lange, Gert L" uniqKey="De Lange G" first="Gert L." last="De Lange">Gert L. De Lange</name>
</author>
<author><name sortKey="Lyaruu, D M" sort="Lyaruu, D M" uniqKey="Lyaruu D" first="D. M." last="Lyaruu">D. M. Lyaruu</name>
</author>
<author><name sortKey="Kuiper, Luit" sort="Kuiper, Luit" uniqKey="Kuiper L" first="Luit" last="Kuiper">Luit Kuiper</name>
</author>
<author><name sortKey="Burger, Elisabeth H" sort="Burger, Elisabeth H" uniqKey="Burger E" first="Elisabeth H." last="Burger">Elisabeth H. Burger</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A3D414AAA5A24834EB2369019663888048ECB67C</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1034/j.1600-0501.2002.130412.x</idno>
<idno type="url">https://api.istex.fr/document/A3D414AAA5A24834EB2369019663888048ECB67C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">005209</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005209</idno>
<idno type="wicri:Area/Istex/Curation">005209</idno>
<idno type="wicri:Area/Istex/Checkpoint">003882</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003882</idno>
<idno type="wicri:doubleKey">0905-7161:2002:Tadjoedin E:high:concentrations:of</idno>
<idno type="wicri:Area/Main/Merge">008766</idno>
<idno type="wicri:Area/Main/Curation">008489</idno>
<idno type="wicri:Area/Main/Exploration">008489</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">High concentrations of bioactive glass material (BioGran<hi rend="superscript">®</hi>
) vs. autogenous bone for sinus floor elevation</title>
<author><name sortKey="Tadjoedin, Ette S" sort="Tadjoedin, Ette S" uniqKey="Tadjoedin E" first="Ette S." last="Tadjoedin">Ette S. Tadjoedin</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Ette S. Tadjoedin, Gert L. de Lange, D. M. Lyaruu, Elisabeth H. Burger, Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam. Van der Boechorststraat 7, 1081 BT, Amsterdam.Luit Kuiper, Department of Oral and Maxillofacial Surgery, ACTA and Hospital Amstelveen, Amstelveen</wicri:regionArea>
<wicri:noRegion>Amstelveen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Lange, Gert L" sort="De Lange, Gert L" uniqKey="De Lange G" first="Gert L." last="De Lange">Gert L. De Lange</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Ette S. Tadjoedin, Gert L. de Lange, D. M. Lyaruu, Elisabeth H. Burger, Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam. Van der Boechorststraat 7, 1081 BT, Amsterdam.Luit Kuiper, Department of Oral and Maxillofacial Surgery, ACTA and Hospital Amstelveen, Amstelveen</wicri:regionArea>
<wicri:noRegion>Amstelveen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lyaruu, D M" sort="Lyaruu, D M" uniqKey="Lyaruu D" first="D. M." last="Lyaruu">D. M. Lyaruu</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Ette S. Tadjoedin, Gert L. de Lange, D. M. Lyaruu, Elisabeth H. Burger, Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam. Van der Boechorststraat 7, 1081 BT, Amsterdam.Luit Kuiper, Department of Oral and Maxillofacial Surgery, ACTA and Hospital Amstelveen, Amstelveen</wicri:regionArea>
<wicri:noRegion>Amstelveen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kuiper, Luit" sort="Kuiper, Luit" uniqKey="Kuiper L" first="Luit" last="Kuiper">Luit Kuiper</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Ette S. Tadjoedin, Gert L. de Lange, D. M. Lyaruu, Elisabeth H. Burger, Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam. Van der Boechorststraat 7, 1081 BT, Amsterdam.Luit Kuiper, Department of Oral and Maxillofacial Surgery, ACTA and Hospital Amstelveen, Amstelveen</wicri:regionArea>
<wicri:noRegion>Amstelveen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Burger, Elisabeth H" sort="Burger, Elisabeth H" uniqKey="Burger E" first="Elisabeth H." last="Burger">Elisabeth H. Burger</name>
<affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Ette S. Tadjoedin, Gert L. de Lange, D. M. Lyaruu, Elisabeth H. Burger, Department of Oral Cell Biology, Academic Center for Dentistry Amsterdam (ACTA), Vrije Universiteit, Amsterdam. Van der Boechorststraat 7, 1081 BT, Amsterdam.Luit Kuiper, Department of Oral and Maxillofacial Surgery, ACTA and Hospital Amstelveen, Amstelveen</wicri:regionArea>
<wicri:noRegion>Amstelveen</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Clinical Oral Implants Research</title>
<title level="j" type="alt">CLINICAL ORAL IMPLANTS RESEARCH</title>
<idno type="ISSN">0905-7161</idno>
<idno type="eISSN">1600-0501</idno>
<imprint><biblScope unit="vol">13</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="428">428</biblScope>
<biblScope unit="page" to="436">436</biblScope>
<biblScope unit="page-count">9</biblScope>
<publisher>Blackwell Science, Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-08">2002-08</date>
</imprint>
<idno type="ISSN">0905-7161</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0905-7161</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>4months</term>
<term>Atrophic maxilla</term>
<term>Augmentation</term>
<term>Autogenous</term>
<term>Autogenous bone</term>
<term>Autogenous bone particles</term>
<term>Bioactive</term>
<term>Bioactive glass</term>
<term>Bioactive glass material</term>
<term>Biopsy</term>
<term>Bone</term>
<term>Bone biopsies</term>
<term>Bone formation</term>
<term>Bone marrow</term>
<term>Bone reconstruction</term>
<term>Bone tissue</term>
<term>Bone volume</term>
<term>Clin</term>
<term>Control side</term>
<term>Dental implants</term>
<term>Elevation</term>
<term>Experimental side</term>
<term>Experimental sides</term>
<term>Goldner staining</term>
<term>Graft</term>
<term>Grafted</term>
<term>High concentration</term>
<term>High concentrations</term>
<term>Histological</term>
<term>Histomorphometrical</term>
<term>Histomorphometry</term>
<term>Hueso</term>
<term>Hueso autogeno</term>
<term>Impl</term>
<term>Implant</term>
<term>Implant placement</term>
<term>Implants research</term>
<term>International journal</term>
<term>Knochen</term>
<term>Lamellar</term>
<term>Lamellar type</term>
<term>Maxilla</term>
<term>Maxillary</term>
<term>Maxillary sinus</term>
<term>Maxillofacial</term>
<term>Maxillofacial implants</term>
<term>Maxillofacial surgery</term>
<term>Meses</term>
<term>Mois</term>
<term>Monaten</term>
<term>Nach</term>
<term>Narrow size range</term>
<term>Oral impl</term>
<term>Osteoid</term>
<term>Osteoid layers</term>
<term>Osteoid surface</term>
<term>Particle</term>
<term>Particules</term>
<term>Preliminary report</term>
<term>Present study</term>
<term>Quatre mois</term>
<term>Resorption</term>
<term>Severe maxillary atrophy</term>
<term>Sinus</term>
<term>Table2</term>
<term>Tadjoedin</term>
<term>Tetracycline</term>
<term>Total bone volume</term>
<term>Trabecular</term>
<term>Trabecular bone</term>
<term>Unstained sections</term>
<term>Xture installation</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>4months</term>
<term>Atrophic maxilla</term>
<term>Augmentation</term>
<term>Autogenous</term>
<term>Autogenous bone</term>
<term>Autogenous bone particles</term>
<term>Bioactive</term>
<term>Bioactive glass</term>
<term>Bioactive glass material</term>
<term>Biopsy</term>
<term>Bone</term>
<term>Bone biopsies</term>
<term>Bone formation</term>
<term>Bone marrow</term>
<term>Bone reconstruction</term>
<term>Bone tissue</term>
<term>Bone volume</term>
<term>Clin</term>
<term>Control side</term>
<term>Dental implants</term>
<term>Elevation</term>
<term>Experimental side</term>
<term>Experimental sides</term>
<term>Goldner staining</term>
<term>Graft</term>
<term>Grafted</term>
<term>High concentration</term>
<term>High concentrations</term>
<term>Histological</term>
<term>Histomorphometrical</term>
<term>Histomorphometry</term>
<term>Hueso</term>
<term>Hueso autogeno</term>
<term>Impl</term>
<term>Implant</term>
<term>Implant placement</term>
<term>Implants research</term>
<term>International journal</term>
<term>Knochen</term>
<term>Lamellar</term>
<term>Lamellar type</term>
<term>Maxilla</term>
<term>Maxillary</term>
<term>Maxillary sinus</term>
<term>Maxillofacial</term>
<term>Maxillofacial implants</term>
<term>Maxillofacial surgery</term>
<term>Meses</term>
<term>Mois</term>
<term>Monaten</term>
<term>Nach</term>
<term>Narrow size range</term>
<term>Oral impl</term>
<term>Osteoid</term>
<term>Osteoid layers</term>
<term>Osteoid surface</term>
<term>Particle</term>
<term>Particules</term>
<term>Preliminary report</term>
<term>Present study</term>
<term>Quatre mois</term>
<term>Resorption</term>
<term>Severe maxillary atrophy</term>
<term>Sinus</term>
<term>Table2</term>
<term>Tadjoedin</term>
<term>Tetracycline</term>
<term>Total bone volume</term>
<term>Trabecular</term>
<term>Trabecular bone</term>
<term>Unstained sections</term>
<term>Xture installation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Abstract: In this study, high concentrations of bioactive glass (BG) particles were compared with autogenous bone in their capacity to augment maxillary bone when grafted in the human sinus floor using a split mouth design. Three female patients with severe maxillary atrophy underwent bilateral sinus floor elevation and bone grafting using 80–100% BG particles (300–355 μm in size) mixed with 20% to 0% iliac crest bone particles at one (experimental) side, and 100% iliac crest derived bone particles at the other (control) side. A total of 22 bone biopsies was taken at the time of fixture installation; that is, at 4, 6 and 15 months after grafting, and processed for histology and histomorphometry. At the control (autogenous bone) sides, trabecular bone amounted to 39% of the biopsy volume in the graft (site) at 4 months, almost 41% at 6 months, and 42% at 15 months. This bone contained viable osteocytes and was mostly of mature, lamellar type. At the experimental (BG particles) sides, the graft consisted of 27% of mostly woven (and some lamellar) bone at 4 months, 36% (woven and lamellar) bone at 6 months, and 39% (mainly lamellar) bone at 15 months. The grafted BG particles started to excavate at 4 months and their centers gradually filled with bone tissue. As a consequence, the volume of BG particles in the biopsy decreased from 29% at 4 months to 15% at 6 months and 8% at 15 months. The BG particles appeared to resorb within 1–2 years by dissolution rather than by osteoclastic activity. Parameters for bone turnover (% osteoid surface, % resorption surface) indicated that bone remodeling was very active at both experimental and control sides, during more than 6 months. These results suggest that mixtures of mainly (80–90%) BG particles and some (10–20%) autogenous bone are effective for bone regeneration in the augmented sinus offer 6 months healing time, while about 12 months healing time is needed for 100% BG particles.</div>
</front>
</TEI>
<affiliations><list><country><li>Pays-Bas</li>
</country>
</list>
<tree><country name="Pays-Bas"><noRegion><name sortKey="Tadjoedin, Ette S" sort="Tadjoedin, Ette S" uniqKey="Tadjoedin E" first="Ette S." last="Tadjoedin">Ette S. Tadjoedin</name>
</noRegion>
<name sortKey="Burger, Elisabeth H" sort="Burger, Elisabeth H" uniqKey="Burger E" first="Elisabeth H." last="Burger">Elisabeth H. Burger</name>
<name sortKey="De Lange, Gert L" sort="De Lange, Gert L" uniqKey="De Lange G" first="Gert L." last="De Lange">Gert L. De Lange</name>
<name sortKey="Kuiper, Luit" sort="Kuiper, Luit" uniqKey="Kuiper L" first="Luit" last="Kuiper">Luit Kuiper</name>
<name sortKey="Lyaruu, D M" sort="Lyaruu, D M" uniqKey="Lyaruu D" first="D. M." last="Lyaruu">D. M. Lyaruu</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008489 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008489 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:A3D414AAA5A24834EB2369019663888048ECB67C |texte= High concentrations of bioactive glass material (BioGran®) vs. autogenous bone for sinus floor elevation }}
This area was generated with Dilib version V0.6.32. |